Non-Animal Softgel Capsule Market

Non-Animal Softgel Capsule Market Size (2023 to 2028)

The global non-animal softgel capsule market size at a global level is expected to be worth USD 17.88 Billion by 2028 from USD 14.84 billion in 2023, growing at a CAGR of 3.8% from 2023 to 2028.

Capsules are an available medication form that is often soft in nature and made of gelatin. Previously, this animal gelatin was used. However, today we have a non-animal version also available. This variant is believed to be more durable, viable, and stable than the animal format. They are similar in nature to the other variants available and can have different shapes, colors, and sizes. These variants are also often lacking all gluten and modified sugars, and with growing love towards body health and hate towards gluten, the market is growing exponentially. They are also thought to have more advantages associated with them, including easy-to-swallow, purity, tastelessness, odorless, safety, kosher or halal certified, clarity, texture, non-brittleness, ease of visible tampering, and others. The increasing geriatric population has prescribed these versions for more comfortable usability. They are often a part of the health industry apart from the pharmaceutical industry. The growing market for environmental products is rampantly helping the non-animal soft gel market to grow.

However, these capsules are relatively more delicate and are also prone to damage easily. The quality of these capsules gets compromised, which can be a danger to the taker. Therefore, a strict quality standard is in place, making the process of approval lengthy, demanding, and expensive.

Further, they also are more expensive than the existing animal gelatin version. It is predictable slow the growth of the global non-animal softgel capsule market substantially. Research in this field is underway, and many big and small players are joining hands to incentivize these drug formats.  

REPORT COVERAGE:

This research report on the global non-animal softgel capsule market has been segmented and sub-segmented based on the product type, application, and region.

Non-Animal Softgel Capsule Market - By Product Type:

• Starches
• Pullulan
• Other

Non-Animal Softgel Capsule Market - By Application:

• Pharmaceutical
• Health Supplements
• Others

Non-Animal Softgel Capsule Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Regionally, APAC is one of the major markets for these capsules because of the growing geriatric population in these regions. The Asia Pacific, as a whole, also holds a significant portion of non-animals in the world, which makes it a massive market for non-animal soft gel capsules. Many countries like Malaysia and Indonesia have a such high demand to export these variants from across other regions. There is also a significant potential market for Europe since health awareness in these regions has been on the rise.

KEY MARKET PLAYERS:

Some of the notable companies leading the global non-animal softgel capsule market profiled in this report are Procaps Laboratories, Bahrain Pharma, Aenova, SIRIO, Robinson Pharma, and Ayanda.

RECENT MARKET HAPPENINGS:

• On May 30, 2019, a whole contract manufacturer of soft gel capsules, which is a nutraceutical and dietary supplement, made a public statement regarding the launch of funding programs by Robinson Pharmacy Inc., inventory support from RPI to help the clients.
• On June 04, 2015, the opening of the first phase of the nutrition facility of USD 81 billion made Amway's public statement. This facility will be added to the Nutrilite Company's manufacturing options for vitamins and minerals and dietary supplements.
• On August 27, 2019, Stride Pharma’s site underwent the U.S. FDA examinations and acquired a manufacturing facility from Micelle BioPharma.
• On March 05, 2019, GNC’ Nutra manufacturing division was integrated into IVC’s operations, which has made a public statement that it has formed a joint venture with the leading nutritional supplement named International Vitamin Corporation.
• On August 04, 2017, J+D labs were finely arranged in the nutraceutical organization, a top leading manufacturer of vitamin, mineral, and nutritional supplements. Captek Sofgel International Inc. a California-based contract manufacturer of custom dietary supplements, has made a public statement that it is acquiring J+D labs.
• On February 07, the Irish conglomerate DCC made its first healthcare with the US, and Elite Company is keeping the focus on producing nutritional products in various packaging formats.